Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, 94158, USA.
California Institute for Quantitative Biosciences, University of California, San Francisco, San Francisco, CA, 94158, USA.
Adv Mater. 2020 Dec;32(52):e2005346. doi: 10.1002/adma.202005346. Epub 2020 Nov 18.
Bioprinting is a powerful technology with the potential to transform medical device manufacturing, organ replacement, and the treatment of diseases and physiologic malformations. However, current bioprinters are unable to reliably print the fundamental unit of all living things, single cells. A high-definition single-cell printing, a novel microfluidic technology, is presented here that can accurately print single cells from a mixture of multiple candidates. The bioprinter employs a highly miniaturized microfluidic sorter to deterministically select single cells of interest for printing, achieving an accuracy of ≈10 µm and speed of ≈100 Hz. This approach is demonstrated by fabricating intricate cell patterns with pre-defined features through selective single-cell printing. The approach is used to synthesize well-defined spheroids with controlled composition and morphology. The speed, accuracy, and flexibility of the approach will advance bioprinting to enable new studies in organoid science, tissue engineering, and spatially targeted cell therapies.
生物打印是一种具有变革性的技术,有望改变医疗器械制造、器官替代以及疾病和生理畸形治疗的方式。然而,当前的生物打印机无法可靠地打印出所有生物的基本单位,即单个细胞。本文提出了一种高清晰度单细胞打印技术,这是一种新颖的微流控技术,可以从多种候选物的混合物中准确地打印单个细胞。该生物打印机采用高度微型化的微流分选器,以确定地选择用于打印的目标单细胞,其精度约为 10 μm,速度约为 100 Hz。通过选择性单细胞打印,该方法可以制造出具有预定特征的复杂细胞图案。该方法还用于合成具有可控组成和形态的规则球体。该方法的速度、精度和灵活性将推动生物打印技术的发展,从而能够开展类器官科学、组织工程和空间靶向细胞疗法等新研究。